ENDRA Life Sciences Inc. (NDRA) vs Skye Bioscience, Inc. (SKYE)
A side-by-side comparison of ENDRA Life Sciences Inc. and Skye Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NDRA
ENDRA Life Sciences Inc.
$6.04HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SKYE
Skye Bioscience, Inc.
$1.62HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NDRA vs SKYE
growth of $100 · dividends reinvested · last 9yNDRA -100.0% (-67.0%/yr)SKYE -99.7% (-47.5%/yr)SKYE compounded faster over this window
Log scale — wide-divergence pair
NDRA SKYE
NDRA vs SKYE: by the numbers
- •NDRA is the larger company ($8M vs $7M market cap).
Metrics side by side
Valuation
| Metric | NDRA | SKYE |
|---|---|---|
| P/B ratio | 1.22 | N/A |
Profitability
| Metric | NDRA | SKYE |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -93.77% | N/A |
| ROIC | -92.93% | N/A |
Growth (annualized)
| Metric | NDRA | SKYE |
|---|---|---|
| Total return CAGR (5Y) | -83.91% | -60.42% |
Frequently asked
- How have NDRA and SKYE total returns compared?
- Over the past 5 years, NDRA delivered -83.91% and SKYE delivered -60.42% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.